← Retour à la une
Golfe & M.-O. · Marchés régionaux · Zawya

Egypt: Ibnsina Pharma records 50% YoY consolidated profit surge in 9 months

Publié par Zawya · Émirats il y a 13 h

Résumé détaillé

Ibnsina Pharma (ISPH) recorded consolidated net profit attributable to the holding company of EGP 908.835 million in the first nine months of 2026, up 50% year on year (YoY) from…

Arab Finance: Ibnsina Pharma (ISPH) recorded consolidated net profit attributable to the holding company of EGP 908.835 million in the first nine months of 2026, up 50% year on year (YoY) from EGP 605.843 million, the company’s financial statements unveiled.

The company’s net sales also soared during the nine months, reaching EGP 68.063 billion, compared to EGP 55.394 billion in the same period of 2025.

Earnings per share stood at EGP 0.73 in January-September 2026, up from EGP 0.53 in the year-ago period.

Meanwhile, the company’s standalone net profit rose to EGP 851.106 million from EGP 638.916 million.

Established in 2001, Ibnsina Pharma is a leading pharmaceutical distribution and healthcare supply chain company.

Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.

Début de l'article, extrait de Zawya. Pour lire la suite, ouvrez l'article chez le média.

Lire l'article complet sur Zawya Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.zawya.com)

À lire aussi